Nkartaincis A Clinical Stage Biopharmaceutical Company Based In South San Franciscocaliforniafounded In 2015Nkarta Specializes In Developing Engineered Natural Killernkcell Therapies Aimed At Treating Cancer And Autoimmune Diseasesthe Company Utilizes Proprietary Technologies For Nk Cell Expansion And Engineering To Create Allogeneicoff The Shelf Cell Therapies That Enhance Accessibility And Effectiveness Compared To Traditional Treatments Nkarta S Product Pipeline Includes Nkx019A Cd19 Targeting Car Nk Therapy Currently In Phase 1 Trials For Autoimmune Conditions And Hematologic Cancersthe Company Also Focuses On Nkx101An Nk Cell Therapy Candidate Targeting Solid And Liquid Tumorsnkarta Collaborates With Crispr Therapeutics To Advance Gene Edited Nk Cell Therapieswith A Dedicated Facility For Research And Developmentnkarta Is Committed To Addressing Unmet Needs In Oncology And Autoimmune Therapeutics Through Scalable Cell Therapy Solutions
| Company Name | Nkarta Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
